SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boston Therapeutics, Inc. Announces Clinical Study Final Results Indicate That SUGARDOWN® Reduced the Post-Meal Elevation of Blood Glucose by Up to 61% in Healthy Volunteers